These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9323591)

  • 1. Adenovirus-mediated expression of hepatic lipase in LCAT transgenic mice.
    Dugi KA; Vaisman BL; Sakai N; Knapper CL; Meyn SM; Brewer HB; Santamarina-Fojo S
    J Lipid Res; 1997 Sep; 38(9):1822-32. PubMed ID: 9323591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice.
    Vaisman BL; Klein HG; Rouis M; Bérard AM; Kindt MR; Talley GD; Meyn SM; Hoyt RF; Marcovina SM; Albers JJ
    J Biol Chem; 1995 May; 270(20):12269-75. PubMed ID: 7744879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential gene therapy for lecithin-cholesterol acyltransferase (LCAT)-deficient and hypoalphalipoproteinemic patients with adenovirus-mediated transfer of human LCAT gene.
    Séguret-Macé S; Latta-Mahieu M; Castro G; Luc G; Fruchart JC; Rubin E; Denèfle P; Duverger N
    Circulation; 1996 Nov; 94(9):2177-84. PubMed ID: 8901669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic lipase expression in macrophages contributes to atherosclerosis in apoE-deficient and LCAT-transgenic mice.
    Nong Z; Gonzalez-Navarro H; Amar M; Freeman L; Knapper C; Neufeld EB; Paigen BJ; Hoyt RF; Fruchart-Najib J; Santamarina-Fojo S
    J Clin Invest; 2003 Aug; 112(3):367-78. PubMed ID: 12897204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring and bioengineered apoA-I mutations that inhibit the conversion of discoidal to spherical HDL: the abnormal HDL phenotypes can be corrected by treatment with LCAT.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochem J; 2007 Aug; 406(1):167-74. PubMed ID: 17506726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes.
    Fournier N; Atger V; Paul JP; de la Llera Moya M; Rothblat G; Moatti N
    Atherosclerosis; 1999 Dec; 147(2):227-35. PubMed ID: 10559507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of hypoalphalipoproteinemia in LDL receptor-deficient rabbits by lecithin:cholesterol acyltransferase.
    Brousseau ME; Wang J; Demosky SJ; Vaisman BL; Talley GD; Santamarina-Fojo S; Brewer HB; Hoeg JM
    J Lipid Res; 1998 Aug; 39(8):1558-67. PubMed ID: 9717715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice.
    Föger B; Chase M; Amar MJ; Vaisman BL; Shamburek RD; Paigen B; Fruchart-Najib J; Paiz JA; Koch CA; Hoyt RF; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1999 Dec; 274(52):36912-20. PubMed ID: 10601244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Natural LCAT Mutations on the Biogenesis of HDL.
    Fotakis P; Kuivenhoven JA; Dafnis E; Kardassis D; Zannis VI
    Biochemistry; 2015 Jun; 54(21):3348-59. PubMed ID: 25948084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration.
    Forte TM; Oda MN; Knoff L; Frei B; Suh J; Harmony JA; Stuart WD; Rubin EM; Ng DS
    J Lipid Res; 1999 Jul; 40(7):1276-83. PubMed ID: 10393212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoproteins, HDL-apolipoproteins, activities of hepatic lipase and lecithin-cholesterol acyltransferase in the plasma of patients with post-alcoholic end-stage liver cirrhosis.
    Breier C; Lisch HJ; Braunsteiner H
    Klin Wochenschr; 1983 Sep; 61(18):929-31. PubMed ID: 6632732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LCAT can rescue the abnormal phenotype produced by the natural ApoA-I mutations (Leu141Arg)Pisa and (Leu159Arg)FIN.
    Koukos G; Chroni A; Duka A; Kardassis D; Zannis VI
    Biochemistry; 2007 Sep; 46(37):10713-21. PubMed ID: 17711302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
    Vaziri ND; Liang K; Parks JS
    Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral expression of human lecithin-cholesterol acyltransferase in nonhuman primates leads to an antiatherogenic lipoprotein phenotype by increasing high-density lipoprotein and lowering low-density lipoprotein.
    Amar MJ; Shamburek RD; Vaisman B; Knapper CL; Foger B; Hoyt RF; Santamarina-Fojo S; Brewer HB; Remaley AT
    Metabolism; 2009 Apr; 58(4):568-75. PubMed ID: 19303980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I.
    Collet X; Tall AR; Serajuddin H; Guendouzi K; Royer L; Oliveira H; Barbaras R; Jiang XC; Francone OL
    J Lipid Res; 1999 Jul; 40(7):1185-93. PubMed ID: 10393203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT.
    Furbee JW; Francone O; Parks JS
    J Lipid Res; 2001 Oct; 42(10):1626-35. PubMed ID: 11590219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.